NCT01025544View on ClinicalTrials.gov

Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention of Haemophilus Influenzae Type b Infections in China

PHASE3CompletedINTERVENTIONAL
Enrollment

846

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

April 30, 2010

Conditions
Haemophilus Influenzae Type b (Hib) Infection
Interventions
BIOLOGICAL

Vaxem Hib (Haemophilus influenzae type b (Hib) vaccine)

Comparator study of two commercially available Haemophilus influenzae type b (Hib) vaccines.

BIOLOGICAL

Hiberix (Haemophilus influenzae type b (Hib) vaccine)

Comparator study of two commercially available Haemophilus influenzae type b (Hib) vaccines.

Trial Locations (1)

Unknown

Hebei Province

Sponsors

Lead Sponsor

Novartis Vaccines
All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY